FundedIQ
Biotechnology

NeuroLife: Funding, Investors & Team (Oct 2026)

NeuroLife is a neurotechnology company bringing more than a decade of research and development into a focused effort to advance wearable neural interface systems.

www.neurolifetech.com LinkedIn Columbus, United States 1-10 employees
Biotechnology Neuroscience B2B
Total raised
$2.9M
Rounds
1
Latest
Seed
Jun 2026

NeuroLife has raised $2.9M across 1 funding round on record, the most recent a Seed of $2.9M announced in Jun 2026.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

NeuroLife Company Profile and Key Stats

Total funding raised
$2.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$2.9M in Jun 2026
Employees
1-10
reported band
Headquarters
Columbus, United States

Latest funding round on record: Jun 2026.

NeuroLife Funding Rounds

Date
Round
Amount
Seed
$2.9M

NeuroLife Founders and Leadership Team

Name
Role
Contact
Jon Snyder
Founder
—

No contact details are on record for this team yet.

NeuroLife Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
17,054
$3.1M

NeuroLife's latest round of $2.9M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like NeuroLife in Biotechnology and Columbus

Companies Similar to NeuroLife

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

NeuroLife Funding FAQs

What does NeuroLife do?

NeuroLife is a neurotechnology company bringing more than a decade of research and development into a focused effort to advance wearable neural interface systems.

How much funding has NeuroLife raised?

NeuroLife has raised $2.9M across 1 round on record. The most recent is a Seed of $2.9M announced in Jun 2026.

When did NeuroLife last raise funding?

NeuroLife's most recent funding round on record is a Seed of $2.9M, announced in Jun 2026.

Who founded NeuroLife?

FundedIQ lists Jon Snyder (Founder) at NeuroLife.

Where is NeuroLife headquartered?

NeuroLife is based in Columbus, Ohio, United States.

How many employees does NeuroLife have?

NeuroLife is in the 1-10 employee band.

How does NeuroLife's funding compare to other Biotechnology startups?

NeuroLife's latest round of $2.9M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's NeuroLife Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NeuroLife is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.